Compare AAPG & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAPG | VVX |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | China | United States |
| Employees | 767 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | N/A | 2014 |
| Metric | AAPG | VVX |
|---|---|---|
| Price | $17.60 | $90.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | $48.40 | ★ $69.88 |
| AVG Volume (30 Days) | 8.8K | ★ 455.6K |
| Earning Date | 05-20-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 126.85 |
| EPS | N/A | ★ 0.60 |
| Revenue | N/A | ★ $4,480,038,000.00 |
| Revenue This Year | $290.34 | $7.81 |
| Revenue Next Year | N/A | $5.84 |
| P/E Ratio | ★ N/A | $150.08 |
| Revenue Growth | N/A | ★ 3.65 |
| 52 Week Low | $16.92 | $43.80 |
| 52 Week High | $48.45 | $91.57 |
| Indicator | AAPG | VVX |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 82.71 |
| Support Level | N/A | $66.71 |
| Resistance Level | $27.98 | N/A |
| Average True Range (ATR) | 0.74 | 2.86 |
| MACD | -0.06 | 0.82 |
| Stochastic Oscillator | 16.43 | 97.27 |
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.